Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120,192,308
-
Total 13F shares
-
16,607,064
-
Share change
-
-2,510,608
-
Total reported value
-
$86,353,974
-
Put/Call ratio
-
244%
-
Price per share
-
$5.20
-
Number of holders
-
62
-
Value change
-
-$13,347,120
-
Number of buys
-
29
-
Number of sells
-
33
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q1 2021
As of 31 Mar 2021,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,607,064 shares.
The largest 10 holders included
Bratton Capital Management, L.P., BlackRock Inc., VANGUARD GROUP INC, Nuveen Asset Management, LLC, Bracebridge Capital, LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, NORTHERN TRUST CORP, and GSA CAPITAL PARTNERS LLP.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.